Home / Inspections / 1174894

FDA Inspection 1174894 — Fresenius Kabi USA LLC

Fresenius Kabi USA LLC — FEI 1450022

The FDA completed an inspection of Fresenius Kabi USA LLC on June 30, 2022 in Melrose Park, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 30, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)

Facility

Other inspections at this facility

  • 1216183 (VAI Thu Aug 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123748 (OAI Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075139 (NAI Mon Dec 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943126 (NAI Fri Sep 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943391 (VAI Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources